- Home
- DVAX vs PINC Comparison
DVAX vs PINC Comparison
Compare DVAX & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- PINC
- Stock Information
- Founded
- DVAX 1996
- PINC 2013
- Country
- DVAX United States
- PINC United States
- Employees
- DVAX N/A
- PINC N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- PINC Other Consumer Services
- Sector
- DVAX Health Care
- PINC Consumer Discretionary
- Exchange
- DVAX Nasdaq
- PINC Nasdaq
- Market Cap
- DVAX 1.7B
- PINC 1.9B
- IPO Year
- DVAX 2004
- PINC 2013
- Fundamental
- Price
- DVAX $12.45
- PINC $22.43
- Analyst Decision
- DVAX Buy
- PINC Hold
- Analyst Count
- DVAX 2
- PINC 7
- Target Price
- DVAX $23.00
- PINC $21.42
- AVG Volume (30 Days)
- DVAX 1.8M
- PINC 1.5M
- Earning Date
- DVAX 02-20-2025
- PINC 02-03-2025
- Dividend Yield
- DVAX N/A
- PINC 3.75%
- EPS Growth
- DVAX N/A
- PINC N/A
- EPS
- DVAX 0.15
- PINC 1.32
- Revenue
- DVAX $260,810,000.00
- PINC $1,325,477,000.00
- Revenue This Year
- DVAX $21.64
- PINC N/A
- Revenue Next Year
- DVAX $19.81
- PINC $1.78
- P/E Ratio
- DVAX $82.38
- PINC $16.70
- Revenue Growth
- DVAX N/A
- PINC 2.65
- 52 Week Low
- DVAX $9.74
- PINC $17.96
- 52 Week High
- DVAX $14.30
- PINC $23.56
- Technical
- Relative Strength Index (RSI)
- DVAX 41.74
- PINC 62.88
- Support Level
- DVAX $12.27
- PINC $21.36
- Resistance Level
- DVAX $12.74
- PINC $21.77
- Average True Range (ATR)
- DVAX 0.35
- PINC 0.58
- MACD
- DVAX -0.06
- PINC 0.12
- Stochastic Oscillator
- DVAX 37.39
- PINC 100.00
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.